RXO Inc has a consensus price target of $18.72, established from looking at the 40 latest analyst ratings. The last 3 analyst ratings were released from Benchmark, Susquehanna, and Susquehanna on April 19, 2024, March 26, 2024, and March 25, 2024. With an average price target of $10.67 between Benchmark, Susquehanna, and Susquehanna, there's an implied -44.99% downside for RXO Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/19/2024 | RXO | Buy Now | RXO | $19.39 | — | Benchmark | Christopher Kuhn | — | Reiterates | → Hold | Get Alert |
03/26/2024 | RXO | Buy Now | RXO | $19.39 | -17.48% | Susquehanna | Bascome Majors | $15 → $16 | Maintains | Negative | Get Alert |
03/25/2024 | RXO | Buy Now | RXO | $19.39 | -17.48% | Susquehanna | Bascome Majors | $15 → $16 | Maintains | Negative | Get Alert |
02/13/2024 | RXO | Buy Now | RXO | $19.39 | 13.46% | Oppenheimer | Scott Schneeberger | $23 → $22 | Maintains | Outperform | Get Alert |
02/09/2024 | RXO | Buy Now | RXO | $19.39 | -22.64% | Susquehanna | Bascome Majors | $18 → $15 | Maintains | Negative | Get Alert |
02/08/2024 | RXO | Buy Now | RXO | $19.39 | 13.46% | B of A Securities | Ken Hoexter | $25 → $22 | Downgrade | Buy → Neutral | Get Alert |
01/10/2024 | RXO | Buy Now | RXO | $19.39 | 13.46% | Stifel | J. Bruce Chan | $20 → $22 | Maintains | Hold | Get Alert |
01/10/2024 | RXO | Buy Now | RXO | $19.39 | 18.62% | Vertical Research | Jeffrey Kauffman | → $23 | Downgrade | Buy → Hold | Get Alert |
10/16/2023 | RXO | Buy Now | RXO | $19.39 | -12.33% | Stifel | J. Bruce Chan | $19 → $17 | Maintains | Hold | Get Alert |
10/11/2023 | RXO | Buy Now | RXO | $19.39 | -17.48% | JP Morgan | Brian Ossenbeck | $17 → $16 | Downgrade | Neutral → Underweight | Get Alert |
10/03/2023 | RXO | Buy Now | RXO | $19.39 | -32.96% | Susquehanna | Bascome Majors | $14 → $13 | Maintains | Negative | Get Alert |
10/02/2023 | RXO | Buy Now | RXO | $19.39 | -7.17% | Morgan Stanley | Ravi Shanker | $20 → $18 | Maintains | Equal-Weight | Get Alert |
08/31/2023 | RXO | Buy Now | RXO | $19.39 | -27.8% | Susquehanna | Bascome Majors | $19 → $14 | Downgrade | Neutral → Negative | Get Alert |
08/07/2023 | RXO | Buy Now | RXO | $19.39 | 23.78% | Oppenheimer | Scott Schneeberger | → $24 | Reiterates | Outperform → Outperform | Get Alert |
08/03/2023 | RXO | Buy Now | RXO | $19.39 | 3.15% | Morgan Stanley | Ravi Shanker | $20 → $20 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
08/03/2023 | RXO | Buy Now | RXO | $19.39 | -2.01% | Stephens & Co. | Jack Atkins | $23 → $19 | Maintains | Equal-Weight | Get Alert |
07/12/2023 | RXO | Buy Now | RXO | $19.39 | -2.01% | Wolfe Research | Scott Group | → $19 | Downgrade | Peer Perform → Underperform | Get Alert |
07/06/2023 | RXO | Buy Now | RXO | $19.39 | 3.15% | Morgan Stanley | Ravi Shanker | $20 → $20 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
06/09/2023 | RXO | Buy Now | RXO | $19.39 | 3.15% | Susquehanna | Bascome Majors | → $20 | Initiates | → Neutral | Get Alert |
The latest price target for RXO (NYSE: RXO) was reported by Benchmark on April 19, 2024. The analyst firm set a price target for $0.00 expecting RXO to fall to within 12 months (a possible -100.00% downside). 21 analyst firms have reported ratings in the last year.
The latest analyst rating for RXO (NYSE: RXO) was provided by Benchmark, and RXO reiterated their hold rating.
There is no last upgrade for RXO.
The last downgrade for RXO Inc happened on February 8, 2024 when B of A Securities changed their price target from $25 to $22 for RXO Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of RXO, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for RXO was filed on April 19, 2024 so you should expect the next rating to be made available sometime around April 19, 2025.
While ratings are subjective and will change, the latest RXO (RXO) rating was a reiterated with a price target of $0.00 to $0.00. The current price RXO (RXO) is trading at is $19.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.